Specific genotype-tumour risk associations provides a basis for novel investigative strategies into succinate dehydrogenase-related mechanisms of tumourigenesis and the development of personalised management for <i>SDHB/SDHC</i>/<i>SDHD</i> mutation carriers. The gene discussed is SDHC; the disease is neoplasm.